Global Drugs for Vulvovaginal Candidiasis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • ID:PD024609
  • August 2018
  • GIR (Global Info Research)
                          

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.

Some women with recurrent candidal infections opt for treatment with over-the-counter (OTC) medications, which generally are highly effective for candidiasis. Preparations for intravaginal administration of butoconazole, clotrimazole, miconazole, and tioconazole are available OTC.

Scope of the Report:
This report focuses on the Drugs for Vulvovaginal Candidiasis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of Drugs for Vulvovaginal Candidiasis includes Cream, Pessary and other. The proportion of Cream in 2017 is about 47.2%, and the proportion of Pessary in 2017 is about 34.1%.
The drugs for Vulvovaginal Candidiasis are Miconazole, Clotrimazole, Fluconazole, Econazole and Other, market share of Fluconazole is about 24.5% in 2017.

Drugs for Vulvovaginal Candidiasis is application in Hospital & Clinic and Pharmacy. The most of Drugs for Vulvovaginal Candidiasis is used in Pharmacy, and the market share in 2016 is about 59%.

The worldwide market for Drugs for Vulvovaginal Candidiasis is expected to grow at a CAGR of roughly 2.1% over the next five years, will reach 870 million US$ in 2023, from 770 million US$ in 2017.

Market Segment by Manufacturers, this report covers

  •     Bayer
  •     Perrigo
  •     J & J
  •     Pfizer
  •     Bristol-Myers Squibb
  •     Effik
  •     Teva
  •     Sanofi
  •     Cisen Pharmaceutical
  •     Kingyork Group

Market Segment by Regions, regional analysis covers
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •     South America (Brazil, Argentina, Colombia etc.)
  •     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •     Cream
  •     Pessary
  •     Other

Market Segment by Applications, can be divided into
  •     Hospital & Clinic
  •     Pharmacy

There are 15 Chapters to deeply display the global Drugs for Vulvovaginal Candidiasis market.
Chapter 1, to describe Drugs for Vulvovaginal Candidiasis Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drugs for Vulvovaginal Candidiasis, with sales, revenue, and price of Drugs for Vulvovaginal Candidiasis, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Vulvovaginal Candidiasis, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drugs for Vulvovaginal Candidiasis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drugs for Vulvovaginal Candidiasis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents
 
1 Market Overview
1.1 Drugs for Vulvovaginal Candidiasis Introduction
1.2 Market Analysis by Type
1.2.1 Cream
1.2.2 Pessary
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Hospital & Clinic
1.3.2 Pharmacy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Perrigo
2.2.1 Business Overview
2.2.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Perrigo Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 J & J
2.3.1 Business Overview
2.3.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 J & J Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Effik
2.6.1 Business Overview
2.6.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Effik Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva
2.7.1 Business Overview
2.7.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cisen Pharmaceutical
2.9.1 Business Overview
2.9.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Kingyork Group
2.10.1 Business Overview
2.10.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2017
3.3.2 Top 6 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Drugs for Vulvovaginal Candidiasis Market Analysis by Regions
4.1 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Regions (2013-2018)
4.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Regions (2013-2018)
4.2 North America Drugs for Vulvovaginal Candidiasis  Sales and Growth Rate (2013-2018)
4.3 Europe Drugs for Vulvovaginal Candidiasis  Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Drugs for Vulvovaginal Candidiasis  Sales and Growth Rate (2013-2018)
4.5 South America Drugs for Vulvovaginal Candidiasis  Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Drugs for Vulvovaginal Candidiasis  Sales and Growth Rate (2013-2018)
5 North America Drugs for Vulvovaginal Candidiasis by Countries
5.1 North America Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Vulvovaginal Candidiasis Sales and Market Share by Countries (2013-2018)
5.1.2 North America Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Countries (2013-2018)
5.2 United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
5.3 Canada Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
5.4 Mexico Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
6 Europe Drugs for Vulvovaginal Candidiasis by Countries
6.1 Europe Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Vulvovaginal Candidiasis Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Countries (2013-2018)
6.2 Germany Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
6.3 UK Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
6.4 France Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
6.5 Russia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
6.6 Italy Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
7 Asia-Pacific Drugs for Vulvovaginal Candidiasis by Countries
7.1 Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Countries (2013-2018)
7.2 China Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
7.3 Japan Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
7.4 Korea Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
7.5 India Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
8 South America Drugs for Vulvovaginal Candidiasis by Countries
8.1 South America Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Vulvovaginal Candidiasis Sales and Market Share by Countries (2013-2018)
8.1.2 South America Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
8.3 Argentina Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
8.4 Colombia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
9 Middle East and Africa Drugs for Vulvovaginal Candidiasis by Countries
9.1 Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
9.3 UAE Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
9.4 Egypt Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
9.5 Nigeria Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
9.6 South Africa Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
10 Global Drugs for Vulvovaginal Candidiasis Market Segment by Type
10.1 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
10.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2013-2018)
10.2 Cream Sales Growth and Price
10.2.1 Global Cream Sales Growth (2013-2018)
10.2.2 Global Cream Price (2013-2018)
10.3 Pessary Sales Growth and Price
10.3.1 Global Pessary Sales Growth (2013-2018)
10.3.2 Global Pessary Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Drugs for Vulvovaginal Candidiasis Market Segment by Application
11.1 Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
11.2 Hospital & Clinic Sales Growth (2013-2018)
11.3 Pharmacy Sales Growth (2013-2018)
12 Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
12.1 Global Drugs for Vulvovaginal Candidiasis Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Vulvovaginal Candidiasis Market Forecast by Regions (2018-2023)
12.2.1 North America Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
12.2.2 Europe Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
12.2.4 South America Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
12.3 Drugs for Vulvovaginal Candidiasis Market Forecast by Type (2018-2023)
12.3.1 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2018-2023)
12.3.2 Global Drugs for Vulvovaginal Candidiasis Market Share Forecast by Type (2018-2023)
12.4 Drugs for Vulvovaginal Candidiasis Market Forecast by Application (2018-2023)
12.4.1 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2018-2023)
12.4.2 Global Drugs for Vulvovaginal Candidiasis Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
 
 
List of Tables and Figures
 
Figure Drugs for Vulvovaginal Candidiasis Picture
Table Product Specifications of Drugs for Vulvovaginal Candidiasis
Figure Global Sales Market Share of Drugs for Vulvovaginal Candidiasis by Types in 2017
Table Drugs for Vulvovaginal Candidiasis Types for Major Manufacturers
Figure Cream Picture
Figure Pessary Picture
Figure Other Picture
Figure Drugs for Vulvovaginal Candidiasis Sales Market Share by Applications in 2017
Figure Hospital & Clinic Picture
Figure Pharmacy Picture
Figure United States Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure France Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure UK Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure China Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure India Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Drugs for Vulvovaginal Candidiasis Revenue (Value) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Vulvovaginal Candidiasis Type and Applications
Table Bayer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Drugs for Vulvovaginal Candidiasis Type and Applications
Table Perrigo Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table J & J Basic Information, Manufacturing Base and Competitors
Table J & J Drugs for Vulvovaginal Candidiasis Type and Applications
Table J & J Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Drugs for Vulvovaginal Candidiasis Type and Applications
Table Pfizer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Type and Applications
Table Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Effik Basic Information, Manufacturing Base and Competitors
Table Effik Drugs for Vulvovaginal Candidiasis Type and Applications
Table Effik Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Drugs for Vulvovaginal Candidiasis Type and Applications
Table Teva Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Drugs for Vulvovaginal Candidiasis Type and Applications
Table Sanofi Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Type and Applications
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kingyork Group Basic Information, Manufacturing Base and Competitors
Table Kingyork Group Drugs for Vulvovaginal Candidiasis Type and Applications
Table Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table Global Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Figure Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Drugs for Vulvovaginal Candidiasis Manufacturer (Revenue) Market Share in 2017
Figure Global Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales by Regions (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Regions (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue by Regions (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Regions in 2013
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Regions in 2017
Figure North America Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure South America Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure North America Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Sales by Countries (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
Figure North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries in 2013
Figure North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries in 2017
Table North America Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries (2013-2018)
Figure North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2013
Figure North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2017
Figure United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Canada Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Mexico Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales by Countries (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2016
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2017
Figure Germany Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure UK Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure France Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Russia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Italy Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales by Countries (2013-2018)
Table Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries 2017
Table Asia-Pacific Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
Figure Asia-Pacific Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries 2017
Figure China Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Korea Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure India Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure South America Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table South America Drugs for Vulvovaginal Candidiasis Sales by Countries (2013-2018)
Table South America Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
Figure South America Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries in 2017
Table South America Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
Table South America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries (2013-2018)
Figure South America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2017
Figure Brazil Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Argentina Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Colombia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales by Countries (2013-2018)
Table Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries in 2017
Table Middle East and Africa Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
Table Middle East and Africa Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2013
Figure Middle East and Africa Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries in 2017
Figure Saudi Arabia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure UAE Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Egypt Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure Nigeria Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Figure South Africa Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Type (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue by Type (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share by Type (2013-2018)
Figure Global Cream Sales Growth (2013-2018)
Figure Global Cream Price (2013-2018)
Figure Global Pessary Sales Growth (2013-2018)
Figure Global Pessary Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Application (2013-2018)
Figure Global Pharmacy Sales Growth (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Sales, Revenue and Growth Rate (2018-2023)
Table Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Regions (2018-2023)
Table Global Drugs for Vulvovaginal Candidiasis Market Share Forecast by Regions (2018-2023)
Figure North America Sales Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
Figure Europe Sales Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
Figure Asia-Pacific Sales Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
Figure South America Sales Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
Figure Middle East and Africa Sales Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
Table Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2018-2023)
Table Global Drugs for Vulvovaginal Candidiasis Market Share Forecast by Type (2018-2023)
Table Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2018-2023)
Table Global Drugs for Vulvovaginal Candidiasis Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Report 2019-2025

The Global Tigecycline Market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Research Report 2019

The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..